Expanding the phenotype of PRPS1 syndromes in females: neuropathy, hearing loss and retinopathy

Orphanet J Rare Dis. 2014 Dec 10;9:190. doi: 10.1186/s13023-014-0190-9.

Abstract

Background: Phosphoribosyl pyrophosphate synthetase (PRS) I deficiency is a rare medical condition caused by missense mutations in PRPS1 that lead to three different phenotypes: Arts Syndrome (MIM 301835), X-linked Charcot-Marie-Tooth (CMTX5, MIM 311070) or X-linked non-syndromic sensorineural deafness (DFN2, MIM 304500). All three are X-linked recessively inherited and males affected display variable degree of central and peripheral neuropathy. We applied whole exome sequencing to a three-generation family with optic atrophy followed by retinitis pigmentosa (RP) in all three cases, and ataxia, progressive peripheral neuropathy and hearing loss with variable presentation.

Methods: Whole exome sequencing was performed in two affecteds and one unaffected member of the family. Sanger sequencing was used to validate and segregate the 12 candidate mutations in the family and to confirm the absence of the novel variant in PRPS1 in 191 controls. The pathogenic role of the novel mutation in PRPS1 was assessed in silico and confirmed by enzymatic determination of PRS activity, mRNA expression and sequencing, and X-chromosome inactivation.

Results: A novel missense mutation was identified in PRPS1 in the affected females. Age of onset, presentation and severity of the phenotype are highly variable in the family: both the proband and her mother have neurological and ophthalmological symptoms, whereas the phenotype of the affected sister is milder and currently confined to the eye. Moreover, only the proband displayed a complete lack of expression of the wild type allele in leukocytes that seems to correlate with the degree of PRS deficiency and the severity of the phenotype. Interestingly, optic atrophy and RP are the only common manifestations to all three females and the only phenotype correlating with the degree of enzyme deficiency.

Conclusions: These results are in line with recent evidence of the existence of intermediate phenotypes in PRS-I deficiency syndromes and demonstrate that females can exhibit a disease phenotype as severe and complex as their male counterparts.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Female
  • Hearing Loss / complications
  • Hearing Loss / diagnosis
  • Hearing Loss / genetics*
  • Humans
  • Male
  • Molecular Sequence Data
  • Mutation, Missense / genetics
  • Pedigree
  • Peripheral Nervous System Diseases / complications
  • Peripheral Nervous System Diseases / diagnosis
  • Peripheral Nervous System Diseases / genetics*
  • Phenotype*
  • Protein Structure, Secondary
  • Purine-Pyrimidine Metabolism, Inborn Errors / complications
  • Purine-Pyrimidine Metabolism, Inborn Errors / diagnosis
  • Purine-Pyrimidine Metabolism, Inborn Errors / genetics*
  • Retinitis Pigmentosa / complications
  • Retinitis Pigmentosa / diagnosis
  • Retinitis Pigmentosa / genetics*
  • Ribose-Phosphate Pyrophosphokinase / deficiency*
  • Ribose-Phosphate Pyrophosphokinase / genetics
  • Syndrome

Substances

  • PRPS1 protein, human
  • Ribose-Phosphate Pyrophosphokinase

Supplementary concepts

  • Phosphoribosylpyrophosphate synthetase deficiency